Can a wearable sensor outsmart diabetic ketoacidosis?

NCT ID NCT07739342

Not yet recruiting Disease control Sponsor: Abbott Diabetes Care Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study looks at whether a wearable device that tracks both glucose and ketones can help people with type 1 diabetes avoid diabetic ketoacidosis (DKA), a serious complication. About 1,200 adults and children with type 1 diabetes will use the Abbott Continuous Dual Glucose Ketone Monitoring System instead of standard care. Researchers will track how often DKA occurs while participants manage their diabetes with this device.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Abbott Continuous Dual Glucose Ketone Monitoring System (a wearable device that continuously measures glucose and ketone levels)
What this could lead to: If successful, this device could help people with type 1 diabetes avoid dangerous episodes of diabetic ketoacidosis by alerting them early to rising ketone levels.
What could go wrong: The trial is observational, so it cannot prove the device directly prevents DKA. Results may vary by age group, and the device's accuracy and user adherence could affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Aotearoa Diabetes Collective

Hamilton, 3204, New Zealand
Health New Zealand-Southern

Dunedin, Otago, 9016, New Zealand
New Zealand Clinical Research

Christchurch, Christchurch Central City, 8011, New Zealand
New Zealand Clinical Research

Wellington, 6011, New Zealand
Optimal Clinical Trials

Auckland, 1010, New Zealand
Optimal Clinical Trials (North)

Rosedale, Auckland, 0632, New Zealand
Te Pae Hauora o Ruahine o Tararua /MidCentral Health New Zealand

Palmerston North, 4414, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.